Greenwich LifeSciences, Inc. (GLSI)
NASDAQ: GLSI · Real-Time Price · USD
8.94
+0.14 (1.59%)
At close: Dec 5, 2025, 4:00 PM EST
8.99
+0.05 (0.55%)
After-hours: Dec 5, 2025, 7:37 PM EST
Greenwich LifeSciences Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Selling, General & Admin | 3.8 | 3.06 | 1.63 | 1.56 | 1.04 | 0.81 | |
| Research & Development | 15.79 | 12.95 | 7.7 | 6.48 | 3.56 | 1.06 | |
| Operating Expenses | 19.59 | 16.01 | 9.33 | 8.04 | 4.6 | 1.86 | |
| Operating Income | -19.59 | -16.01 | -9.33 | -8.04 | -4.6 | -1.86 | |
| Interest & Investment Income | 0.11 | 0.22 | 0.44 | 0.22 | 0.03 | 0 | |
| Pretax Income | -19.48 | -15.79 | -8.89 | -7.83 | -4.57 | -1.86 | |
| Net Income | -19.48 | -15.79 | -8.89 | -7.83 | -4.57 | -1.86 | |
| Net Income to Common | -19.48 | -15.79 | -8.89 | -7.83 | -4.57 | -1.86 | |
| Shares Outstanding (Basic) | 13 | 13 | 13 | 13 | 13 | 9 | |
| Shares Outstanding (Diluted) | 13 | 13 | 13 | 13 | 13 | 9 | |
| Shares Change (YoY) | 3.05% | 1.29% | -0.51% | -0.23% | 36.27% | 320.69% | |
| EPS (Basic) | -1.46 | -1.21 | -0.69 | -0.61 | -0.35 | -0.20 | |
| EPS (Diluted) | -1.46 | -1.21 | -0.69 | -0.61 | -0.35 | -0.20 | |
| EBITDA | -19.58 | -16.01 | -9.32 | -8.04 | -4.59 | -1.86 | |
| D&A For EBITDA | 0 | 0 | 0 | 0 | 0 | 0 | |
| EBIT | -19.59 | -16.01 | -9.33 | -8.04 | -4.6 | -1.86 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.